| ign="center"> | | | | investment or "outperform the broader market." |
| The U.S. biotechnology and medical device businesses, | | | | A long time, has relied on the traditional |
| 2007 was another bumper year. | | | | pharmaceutical companies to develop products using |
| In the industry had the largest VC deal, clearly | | | | chemical methods, and bio-pharmaceutical companies |
| revealing Venture capitalists are now most concerned | | | | is the use of genes and cells to develop for the |
| about what is | | | | treatment of cancer, arthritis and other diseases. |
| "International accounting firm | | | | Now, traditional pharmaceutical companies have |
| PricewaterhouseCoopers and the National Venture | | | | realized they can not be ignored biopharmaceutical |
| Capital Association recently issued a joint report on | | | | company, therefore, are willing to invest large sums |
| venture capital to. Report that, in 2007, venture | | | | of money with the biopharmaceutical company |
| capitalists to the U.S. bio-pharmaceutical companies | | | | formed a strategic alliance designed to accelerate the |
| and medical device company into a 9.1 billion of funds, | | | | development of new products to replace expiring |
| setting a new high over the years. " | | | | patents existing products. |
| 2007, and fund-raising increased by 20% | | | | Philadelphia manages 600 million U.S. dollars, a venture |
| According to the report of PricewaterhouseCoopers | | | | fund QuakerBioventures founder partner SherrillNeff |
| open in 2007, venture capitalists into U.S. investment | | | | said: "The prospect of some large pharmaceutical |
| company industry, 3813 was 29.4 billion U.S. dollars of | | | | companies is not good for us this is good news |
| capital investment since 2001 is the highest; of which | | | | indeed, we are in are venture capital support for |
| about 31% of the funds that 9.1 billion U.S. dollars to | | | | biopharmaceutical companies and large pharmaceutical |
| invest in the bio-pharmaceutical and medical device | | | | companies are closely aligned with the primary stage. |
| industries, making bio-pharmaceutical and medical | | | | " |
| device company funds raised higher than 20% in | | | | At a press conference earlier, SherrillNeff said |
| 2006, reaching the highest ever recorded. | | | | investors continued to pound the biopharmaceutical |
| To invest in other industries such as software | | | | industry funds is that the industry has a large |
| industry capital of 5.3 billion, up 2.7%; to invest in | | | | pharmaceutical company needed to bring long-term |
| Internet companies was 4.6 billion U.S. dollars of | | | | innovation, large-scale system Pharmaceutical |
| funds, an increase of 12%. Overall, the United States | | | | companies have a small-scale companies do not have |
| acquired the wind all industries increased by 11% of | | | | the cash flow, marketing expertise and so on, so |
| the vote, but in comparison, bio-pharmaceutical and | | | | they naturally become the latter's cooperation |
| medical device industry, 20% growth in wind | | | | partners and acquirers. |